Sharmeh has announced its quarterly financial results for the third quarter of fiscal year 2026, marking another milestone in the company's regulatory compliance and transparency efforts. The healthcare services provider released its unaudited standalone financial results for the quarter ended December 31, 2025, following comprehensive board review and approval.

Board Meeting and Approval Process

The company's Board of Directors convened on February 14, 2026, at the registered office located at Jaipur Hospital, Near SMS Stadium, Lal Kothi, Tonk Road, Jaipur. The meeting details and outcomes are summarized below:

The board meeting was conducted in accordance with regulatory requirements, with Company Secretary and Compliance Officer Bhawana Sharma (Membership No. A61665) overseeing the compliance aspects of the announcement.

Regulatory Compliance and Standards

The financial results have been prepared in strict adherence to Indian Accounting Standards (Ind AS) as specified under Section 133 of the Companies Act, 2013. The company has ensured compliance with Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, including all relevant amendments and circulars issued by SEBI.

Key compliance highlights include:

• IND-AS compliant standalone unaudited financial results
• Limited review conducted by statutory auditors
• Audit Committee review and board approval
• Timely submission to BSE Limited (Scrip Code: 524548)

Independent Auditor Review

Gopal Sharma & Co., Chartered Accountants, conducted an independent limited review of the quarterly financial results. Partner CA Abhishek Sharma (Membership No. 079224) signed off on the review report dated February 14, 2026. The auditing firm, with registration number 002803C, confirmed that the financial statements comply with Indian Accounting Standards and disclosure requirements.

Corporate Structure and Communication

Sharma East India Hospitals & Medical Research Limited operates with its registered office in Jaipur, Rajasthan, and maintains active communication channels for stakeholders. The company's CIN is L85110RJ1989PLC005206, reflecting its incorporation in 1989 under the hospital and medical research sector classification.

The company has made the quarterly results announcement available on its official website at www.jaipurhospital.co.in , ensuring transparent access to financial information for all stakeholders. The organization continues to maintain its commitment to regulatory compliance and timely disclosure of material information to the stock exchanges and investors.

SHARMEH has announced the reappointment of Dr. Shailendra Kumar Sharma as Managing Director for a three-year term, subject to shareholder approval at the upcoming Annual General Meeting (AGM).

Board Approval and Tenure

The Board of Directors, in their meeting held on September 6, 2025, approved Dr. Sharma's reappointment based on recommendations from the Nomination and Remuneration Committee. The new term is set to commence from September 7, 2025, and will continue until September 6, 2028.

Dr. Shailendra Kumar Sharma's Profile

Dr. Shailendra Kumar Sharma is a renowned orthopedic surgeon with 42 years of experience in the hospital industry. His contributions to the field include:

• Establishing the first orthopedic surgeon-owned hospital in Rajasthan in 1983
• Pioneering knee replacement procedures in Jaipur
• Receiving recognition as a "Pioneer in Orthopaedic work" by the Medical Practitioners Society of Rajasthan
• Being awarded as an "Entrepreneur in Medicine" at the Golden Jubilee Celebration of SMS Medical College

Family Ties within the Company

Dr. Sharma has familial connections within the company's leadership:

• Father of Dr. Karan Sharma and Dr. Radhika Sathe, both serving as Directors
• Spouse of Maya Sharma, who is also a Director

Annual General Meeting and Other Corporate Actions

The company has announced several important dates and actions:

• The 36th AGM is scheduled for September 30, 2025, at 3:00 p.m. IST via Video Conferencing (VC) or Other Audio-Visual Means (OAVM)
• The Register of Members and Share Transfer Books will be closed from September 24, 2025, to September 30, 2025 (both days inclusive)
• E-voting for shareholders will be available from September 27, 2025, at 9:00 a.m. to September 29, 2025, at 5:00 p.m.

Shareholders will have the opportunity to vote on Dr. Sharma's reappointment and other matters during the upcoming AGM.

The reappointment of Dr. Shailendra Kumar Sharma, with his extensive experience and contributions to the field of orthopedics, signals continuity in SHARMEH's leadership as it moves forward in the healthcare sector.